Quantcast

Posts related to ‘MNKD’

BioHealth Business Daily (CTIC, DNDN, MNKD, VPHM, SOMX, SQNM, TEVA, RNN, BIIB)

Posted: March 22, 2010 at 12:57 pm

Monday is seeing many winners and losers in the healthcare sector on the heels of the health care reform passage in the House of Representatives this weekend.  We are focusing ...
Read Full Story »

The Unusual Suspects (AA, INTC, JPM, BRK-A, CYCC, GENZ, IMMU, MNKD, QCOM, SWC)

Posted: January 9, 2010 at 10:23 am

There are many companies that deserved to be on this weekend's slate of unusual suspects that have key current developments to watch in this coming week.  Some are unusual trading activity, ...
Read Full Story »

Top Day Trader Alerts (GE, PALM, VVUS, OREX, ARNA, MNKD)

Posted: September 9, 2009 at 9:27 am

Here are Wednesday's top day trader and active trader alerts with more detailed trading volume and price analysis in the links over at VSInvestor.com: General Electric Co. (NYSE:GE) is challenging ...
Read Full Story »
Biotech Image

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Posted: August 10, 2009 at 10:56 am

Diabetes is becoming an epidemic in the U.S. and the Western World.  The ties to obesity are often direct, so the potential treatments are often directly tied as well.  We ...
Read Full Story »
Money Stack Image

Long Line of Biotech Secondary Stock Offerings (MNKD, IDIX, ISPH, ARIA, ONTY, NBY, SOMX, ARNA, OXGN)

Posted: August 5, 2009 at 1:28 pm

It seems that there is another endless line of biotech and emerging pharmaceutical companies which have raised cash or have filed to raise cash.  MannKind Corporation (NASDAQ: MNKD), Idenix Pharmaceuticals ...
Read Full Story »
Money Stack Image

MannKind Raises Over $50 Million (MNKD, PFE)

Posted: August 5, 2009 at 9:55 am

MannKind Corporation (NASDAQ: MNKD) is getting hit after the company announced that it priced a secondary offering of 7,400,000 shares of its common stock.  While the press release does not ...
Read Full Story »
biotech

The Next Blockbuster Drugs: A $170 Billion Opportunity

Posted: July 22, 2009 at 4:01 am

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential ...
Read Full Story »

Biotech Business Daily (BTRX, BMRN, DSCO, ENDP, MNKD, MIPI, QSC, TECH)

Posted: April 30, 2008 at 3:21 pm

Today almost feels like the "March of Biotech-inguins" because most of the movers were small companies you might otherwise miss.  Here were the big movers: Barrier Therapeutics (NASDAQ: BTRX) ran ...
Read Full Story »

Biotech Busine$$ Daily (ALKS, CADX, CVTX, MNKD, GNBT, PPHM)

Posted: April 14, 2008 at 12:16 pm

Alkermes (NASDAQ: ALKS) and Johnson & Johnson Pharmaceutical Research and Developed today submitted paperwork seeking approval of their partnership drug, RISPERDAL CONSTA, to be allowed for treatment of bipolar disorder ...
Read Full Story »

The 52-Week Low Club (BID)(AVR)(MNKD)(GRMN)(SSCC)

Posted: April 9, 2008 at 2:40 pm

Sotheby's Holdings (BID) Market is turning against companies with rick customers are they become poor. Fallst to $24.37 from 52-week high of $61.40. Aventine Renewable Energy (AVR) Crop prices go ...
Read Full Story »

Biotech Monday (CRIS, CGRB, EXEL, MNKD, PDLI, SQNM, TCM)

Posted: March 10, 2008 at 2:25 pm

Curis Inc. (NASDAQ: CRIS) shares down 18% after development partner Wyeth terminated their contract that focused on cancer treatment developments. Shares are down $0.29 to $1.14. The 52 week range ...
Read Full Story »

Earlybird Analyst Calls (June 14, 2007)

Posted: June 14, 2007 at 6:29 am

ACL started as Buy at Jefferies.AMGN started as Mkt Perform at Rodman & Renshaw.B started as Outperform at CIBC.CBB started as Buy at UBS.CHE started as Buy at Jefferies.CTL raised ...
Read Full Story »